🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 16 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
26/09/2005 29,50 30,00 29,00 29,20 -1,02% 3,39% 970
23/09/2005 29,20 29,50 29,00 29,50 +0,17% 1,71% 1.670
22/09/2005 29,00 29,90 28,90 29,45 +0,51% 3,45% 2.040
21/09/2005 30,00 30,10 29,30 29,30 -2,66% 2,67% 3.540
20/09/2005 29,70 30,10 28,80 30,10 +1,01% 4,38% 5.860
19/09/2005 30,50 30,70 28,10 29,80 -1,65% 8,52% 7.310
16/09/2005 30,79 31,00 29,40 30,30 +2,02% 5,20% 5.430
15/09/2005 30,60 31,10 29,40 29,70 -0,34% 5,56% 7.090
14/09/2005 30,00 30,50 29,60 29,80 -0,67% 3,00% 2.080
13/09/2005 30,10 30,10 29,60 30,00 +0,00% 1,66% 1.090
12/09/2005 31,40 31,40 28,50 30,00 -0,66% 9,24% 4.000
09/09/2005 30,00 30,90 29,50 30,20 +2,37% 4,67% 9.160
08/09/2005 30,30 30,30 28,71 29,50 +2,43% 5,25% 7.920
07/09/2005 26,00 29,80 26,00 28,80 +10,77% 14,62% 8.090
06/09/2005 29,50 29,50 25,60 26,00 -1,52% 13,22% 7.170
02/09/2005 26,60 26,60 26,20 26,40 -1,12% 1,50% 2.040
01/09/2005 26,50 27,00 26,50 26,70 +2,69% 1,89% 9.310
31/08/2005 26,30 26,30 25,50 26,00 +1,33% 3,04% 3.160
30/08/2005 26,00 26,00 25,30 25,66 -0,54% 2,69% 3.750
29/08/2005 25,60 26,00 25,20 25,80 -1,53% 3,13% 1.680
26/08/2005 26,30 26,30 25,70 26,20 +0,77% 2,28% 2.760
25/08/2005 26,10 26,40 25,40 26,00 +0,00% 3,83% 10.540
24/08/2005 25,00 26,00 25,00 26,00 +4,42% 4,00% 5.640
23/08/2005 27,20 27,20 24,70 24,90 -9,06% 9,19% 19.330
22/08/2005 27,50 28,10 27,00 27,38 +0,29% 4,00% 14.360
19/08/2005 27,50 27,50 26,00 27,30 +1,11% 5,45% 6.020
18/08/2005 26,50 27,00 25,80 27,00 +0,00% 4,53% 7.820
17/08/2005 27,20 27,80 26,60 27,00 -2,53% 4,41% 9.170
16/08/2005 28,00 28,50 27,50 27,70 -1,07% 3,57% 7.050
15/08/2005 28,50 29,00 27,60 28,00 +0,00% 4,91% 4.990